Lung Kee (Bermuda) Holdings Limited (HK:0255)
:0255
Want to see HK:0255 full AI Analyst Report?
0255 Stock Chart & Stats
HK$1.65
HK$0.04(3.51%)
At close: 4:00 PM EST
HK$1.65
HK$0.04(3.51%)
Day’s Range― - ―
52-Week RangeHK$1.26 - HK$1.98
Previous CloseN/A
Volume86.00K
Average Volume (3M)41.87K
Market Cap
HK$982.71M
Enterprise ValueHK$398.25M
Total Cash (Recent Filing)HK$588.63M
Total Debt (Recent Filing)HK$4.36M
Price to Earnings (P/E)―
Beta0.38
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield14.77%
Share Statistics
EPS (TTM)-0.04
Shares Outstanding634,007,300
10 Day Avg. Volume75,200
30 Day Avg. Volume41,866
Financial Highlights & Ratios
PEG Ratio-0.73
Price to Book (P/B)0.70
Price to Sales (P/S)0.82
P/FCF Ratio6.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetA near-zero debt-to-equity profile gives the company durable financial flexibility to fund operations, capex, and working capital during downturns. Low leverage materially reduces solvency risk, enabling strategic responses and supporting long-term operational continuity even while earnings recover.
Resilient Operating Cash FlowConsistent positive operating cash flow and recent positive free cash flow indicate the business generates real cash despite accounting losses. This cash conversion supports ongoing operations, funds dividends/capex selectively, and underpins financial stability over the next several quarters.
Positive Underlying EBITDASustained positive EBITDA implies the core manufacturing business still produces operating earnings before non-cash charges. That suggests pricing or cost structure retains fundamentals to restore net profitability if revenue stabilizes, supporting medium-term recovery potential.
Bears Say
Multi-year Net LossesThree consecutive years of net losses indicate persistent profitability shortfalls. Continued operating deficits constrain retained earnings, limit reinvestment capacity, and require reliance on cash reserves or asset sales to maintain dividends or capex, weakening long-term earnings credibility.
Revenue Contraction TrendRenewed top-line decline signals weakening demand or loss of pricing/volume in core mold components markets. Structural revenue shrinkage undermines scale economics, pressures margins, and makes it harder to restore operating leverage, prolonging recovery and stressing fixed-cost absorption.
Inconsistent Free Cash Flow & Margin PressureIrregular free cash flow and negative operating margins show cash generation is vulnerable to cyclical swings and cost pressures. This inconsistency raises the risk that future downturns could curtail capex, dividends, or necessary investments, limiting long-term growth and competitiveness.
Lung Kee (Bermuda) Holdings Limited News
0255 FAQ
What was Lung Kee (Bermuda) Holdings Limited’s price range in the past 12 months?
Lung Kee (Bermuda) Holdings Limited lowest stock price was HK$1.26 and its highest was HK$1.98 in the past 12 months.
What is Lung Kee (Bermuda) Holdings Limited’s market cap?
Lung Kee (Bermuda) Holdings Limited’s market cap is HK$982.71M.
When is Lung Kee (Bermuda) Holdings Limited’s upcoming earnings report date?
Lung Kee (Bermuda) Holdings Limited’s upcoming earnings report date is Aug 21, 2026 which is in 108 days.
How were Lung Kee (Bermuda) Holdings Limited’s earnings last quarter?
Lung Kee (Bermuda) Holdings Limited released its earnings results on Mar 20, 2026. The company reported -HK$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.03.
Is Lung Kee (Bermuda) Holdings Limited overvalued?
According to Wall Street analysts Lung Kee (Bermuda) Holdings Limited’s price is currently Overvalued.
Does Lung Kee (Bermuda) Holdings Limited pay dividends?
Lung Kee (Bermuda) Holdings Limited pays a Annually dividend of HK$0.08 which represents an annual dividend yield of 14.77%. See more information on Lung Kee (Bermuda) Holdings Limited dividends here
What is Lung Kee (Bermuda) Holdings Limited’s EPS estimate?
Lung Kee (Bermuda) Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lung Kee (Bermuda) Holdings Limited have?
Lung Kee (Bermuda) Holdings Limited has 634,007,300 shares outstanding.
What happened to Lung Kee (Bermuda) Holdings Limited’s price movement after its last earnings report?
Lung Kee (Bermuda) Holdings Limited reported an EPS of -HK$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.709%.
Which hedge fund is a major shareholder of Lung Kee (Bermuda) Holdings Limited?
Currently, no hedge funds are holding shares in HK:0255
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lung Kee (Bermuda) Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
95.35%
12-Months-Change
Fundamentals
Return on Equity
-1.44%
Trailing 12-Months
Asset Growth
-7.80%
Trailing 12-Months
Company Description
Lung Kee (Bermuda) Holdings Limited
Lung Kee (Bermuda) Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People's Republic of China and internationally. The company was founded in 1975 and is headquartered in Sha Tin, Hong Kong. Lung Kee (Bermuda) Holdings Limited is a subsidiary of Pan Island Investments Limited.
Technical Analysis
Ka Shui International Holdings Limited
―
Eva Precision Industrial Holdings Limited
―
IPE Group Limited
―
Karrie International Holdings Limited
―
KFM Kingdom Holdings Ltd.
―
Options Prices
Currently, No data available
---